Dr. Michael Anger is senior vice president and chief medical officer of the Renal Therapies Group of Fresenius Medical Care, North America and the chief medical officer of Frenova. His medical training and internal medicine residency were at Hahnemann University and his adult and pediatric nephrology fellowships at the University of Colorado School of Medicine. He is clinical professor of medicine at the University of Colorado School of Medicine, fellow of the American College of Physicians, fellow of the American Society of Nephrology and member of the honor medical society Alpha Omega Alpha. Prior to joining Fresenius, Dr. Anger had been the chief medical officer of American Renal Associates as well as president and senior partner of Western Nephrology in Denver, Colorado. There, he also led the research division and interventional nephrology.